Utility of intraluminal thrombolytic therapy for tunnelled haemodialysis catheter dysfunction

No Thumbnail Available
File version
Author(s)
Yaxley, J
Kurtkoti, J
Stockwell, L
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location

Virtual

License
Abstract

Aim: To evaluate local practices and the utility of common interventions for tunnelled haemodialysis catheter dysfunction.

Background: Catheter dysfunction is a common problem, usually as a result of intraluminal thrombosis. Although scientific evidence is lacking, protocols recommend various conservative measures prior to catheter replacement, such as chest radiography to confirm line position, evaluating fluid status to avoid hypovolaemia, and thrombolytic therapy.

Methods: We performed a retrospective chart review of all patients receiving intra‐catheter thrombolysis for catheter dysfunction, over 12 months from August 2018 in our metropolitan hospital network. After presenting initial findings to our renal department and instituting a protocol, identical data were prospectively audited for a further 6 months.

Results: Thrombolytic therapy was prescribed on 66 occasions over 12 months. Adherence to general guideline recommendations was low. Prior to thrombolysis, chest x‐ray and fluid status was reviewed in only 39% and 18% of patients respectively. Objective criteria defining actual catheter dysfunction was documented in only 44% of patients. Overall, thrombolysis successfully reversed catheter dysfunction in 56% of cases. Chest radiograph acquisition, volume status optimization, and documented presence of actual dysfunction were each associated with greater thrombolysis efficacy. Median catheter survival following thrombolysis was 40 days, and catheter patency at 3 months was 31%. Following our staff education session thrombolytic prescriptions declined by more than 50%. This was accompanied by wider use of protocoled measures and better thrombolysis efficacy. Overall success increased to 75% with a median catheter survival of 75 days.

Conclusion: Thrombolytic therapy successfully remediates haemodialysis catheter dysfunction in the majority of cases. Within the limits of a chart review design our findings indicate that observation of routine non‐pharmacological measures and confirmation of catheter dysfunction by objective numerical criteria prior to its use are associated with improved efficacy.

Journal Title
Conference Title

Nephrology

Book Title
Edition
Volume

25

Issue

S3

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Clinical sciences

Science & Technology

Life Sciences & Biomedicine

Urology & Nephrology

Persistent link to this record
Citation

Yaxley, J; Kurtkoti, J; Stockwell, L,Utility of intraluminal thrombolytic therapy for tunnelled haemodialysis catheter dysfunction, Nephrology, 2020, 25, pp. 74-74